Hironori Nishibori1, Hiroki Kato2, Masaya Kawaguchi3, Akihito Nagano4, Masayuki Matsuo3. 1. Department of Radiology, Kizawa Memorial Hospital, 590 Shimokobi, Kobi-cho, Minokamo City, Gifu, 505-8503, Japan. 2. Department of Radiology, Gifu University School of Medicine, 1-1 Yanagido, Gifu, 501-1194, Japan. hkato@gifu-u.ac.jp. 3. Department of Radiology, Gifu University School of Medicine, 1-1 Yanagido, Gifu, 501-1194, Japan. 4. Department of Orthopedic Surgery, Gifu University School of Medicine, Gifu, Japan.
Abstract
PURPOSE: To assess the correlation between T2*-weighted MR imaging and pathological findings of giant cell tumors (GCT) of bone. METHODS: Of the 33 patients with histopathologically proven GCT of bone, 12 were examined using 1.5-T MR imaging, including T2*-weighted imaging, and were included in this study. The imaging and pathological findings of GCTs were compared between GCTs with and without hypointensity on T2*-weighted images (T2* hypointensity). RESULTS: T2* hypointensity was observed in 6 out of 12 (50%) GCTs. Septal formation (83% vs. 17%; p < 0.05) and cystic formation (67% vs. 0%; p < 0.05) on T2-weighted images was significantly more frequent in the GCTs with T2* hypointensity compared with those without T2* hypointensity. Among the six GCTs with T2* hypointensity, a large amount of hemosiderin deposition was pathologically observed in five (83%) cases, whereas small amounts of hemosiderin deposition was seen in one (17%) case. In contrast, among the six GCTs without T2* hypointensity, a small amount of hemosiderin deposition was pathologically observed in all six (100%). CONCLUSION: Half of the GCTs showed T2* hypointensity, which is characteristic of hemosiderin deposition; whereas, the other half did not show T2* hypointensity due to a small amount of hemosiderin deposition.
PURPOSE: To assess the correlation between T2*-weighted MR imaging and pathological findings of giant cell tumors (GCT) of bone. METHODS: Of the 33 patients with histopathologically proven GCT of bone, 12 were examined using 1.5-T MR imaging, including T2*-weighted imaging, and were included in this study. The imaging and pathological findings of GCTs were compared between GCTs with and without hypointensity on T2*-weighted images (T2* hypointensity). RESULTS: T2* hypointensity was observed in 6 out of 12 (50%) GCTs. Septal formation (83% vs. 17%; p < 0.05) and cystic formation (67% vs. 0%; p < 0.05) on T2-weighted images was significantly more frequent in the GCTs with T2* hypointensity compared with those without T2* hypointensity. Among the six GCTs with T2* hypointensity, a large amount of hemosiderin deposition was pathologically observed in five (83%) cases, whereas small amounts of hemosiderin deposition was seen in one (17%) case. In contrast, among the six GCTs without T2* hypointensity, a small amount of hemosiderin deposition was pathologically observed in all six (100%). CONCLUSION: Half of the GCTs showed T2* hypointensity, which is characteristic of hemosiderin deposition; whereas, the other half did not show T2* hypointensity due to a small amount of hemosiderin deposition.
Entities:
Keywords:
Giant cell tumors of bone; Hemosiderin; MRI; T2*-weighted images
Authors: S Shams; J Martola; L Cavallin; T Granberg; M Shams; P Aspelin; L O Wahlund; M Kristoffersen-Wiberg Journal: AJNR Am J Neuroradiol Date: 2015-02-19 Impact factor: 3.825
Authors: Corey J Chakarun; Deborah M Forrester; Christopher J Gottsegen; Dakshesh B Patel; Eric A White; George R Matcuk Journal: Radiographics Date: 2013 Jan-Feb Impact factor: 5.333
Authors: J Aoki; K Moriya; K Yamashita; F Fujioka; K Ishii; O Karakida; S Imai; F Sakai; Y Imai; S Sone Journal: J Comput Assist Tomogr Date: 1991 Nov-Dec Impact factor: 1.826
Authors: F Fazekas; R Kleinert; G Roob; G Kleinert; P Kapeller; R Schmidt; H P Hartung Journal: AJNR Am J Neuroradiol Date: 1999-04 Impact factor: 3.825